HealthCor Management as of June 30, 2022
Portfolio Holdings for HealthCor Management
HealthCor Management holds 56 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Boston Scientific Corporation Call Option (BSX) | 8.6 | $86M | 2.3M | 37.27 | |
Biogen Idec (BIIB) | 8.5 | $84M | 414k | 203.94 | |
Horizon Therapeutics Pub L SHS | 7.2 | $72M | 904k | 79.76 | |
BioMarin Pharmaceutical (BMRN) | 6.2 | $61M | 741k | 82.87 | |
Centene Corporation (CNC) | 4.6 | $46M | 541k | 84.61 | |
UnitedHealth (UNH) | 3.5 | $35M | 68k | 513.63 | |
Natera (NTRA) | 3.2 | $32M | 898k | 35.44 | |
Bristol Myers Squibb (BMY) | 3.2 | $32M | 412k | 77.00 | |
Livanova SHS (LIVN) | 3.1 | $30M | 487k | 62.47 | |
Chemocentryx Call Option | 3.0 | $30M | 1.2M | 24.78 | |
Hologic (HOLX) | 2.8 | $28M | 402k | 69.30 | |
Tenet Healthcare Corp Com New (THC) | 2.7 | $27M | 519k | 52.56 | |
Anthem (ELV) | 2.6 | $26M | 54k | 482.57 | |
Cigna Corp (CI) | 2.6 | $25M | 97k | 263.52 | |
Danaher Corporation (DHR) | 2.5 | $25M | 97k | 253.52 | |
Eli Lilly & Co. (LLY) | 2.3 | $23M | 71k | 324.22 | |
AmerisourceBergen (COR) | 2.2 | $22M | 157k | 141.48 | |
Humana (HUM) | 2.2 | $22M | 47k | 468.06 | |
Abbott Laboratories (ABT) | 2.2 | $22M | 199k | 108.65 | |
Revance Therapeutics (RVNC) | 2.0 | $20M | 1.4M | 13.82 | |
Henry Schein (HSIC) | 1.9 | $19M | 249k | 76.74 | |
Cytokinetics Com New (CYTK) | 1.9 | $19M | 486k | 39.29 | |
Seagen | 1.8 | $18M | 103k | 176.94 | |
Incyte Corporation (INCY) | 1.8 | $18M | 234k | 75.97 | |
Syndax Pharmaceuticals (SNDX) | 1.8 | $18M | 923k | 19.24 | |
Agilent Technologies Inc C ommon (A) | 1.7 | $16M | 138k | 118.77 | |
Intuitive Surgical Com New (ISRG) | 1.5 | $15M | 73k | 200.70 | |
Becton, Dickinson and (BDX) | 1.4 | $14M | 56k | 246.53 | |
Universal Hlth Svcs CL B (UHS) | 1.4 | $14M | 134k | 100.71 | |
McKesson Corporation (MCK) | 1.1 | $11M | 35k | 326.20 | |
Kezar Life Sciences (KZR) | 1.0 | $10M | 1.2M | 8.27 | |
Cooper Cos Com New | 1.0 | $9.6M | 31k | 313.13 | |
Zimmer Holdings (ZBH) | 0.8 | $7.6M | 72k | 105.05 | |
Ishares Tr Ishares Biotech (IBB) | 0.6 | $6.3M | 54k | 117.63 | |
Hyperfine Com Cl A (HYPR) | 0.6 | $6.1M | 2.7M | 2.23 | |
Dex (DXCM) | 0.6 | $5.6M | 75k | 74.53 | |
Affimed Therapeutics B V | 0.5 | $4.8M | 1.7M | 2.77 | |
Select Sector Spdr Tr Sbi Healthcare (XLV) | 0.4 | $4.4M | 35k | 128.23 | |
Rapt Therapeutics (RAPT) | 0.4 | $4.0M | 217k | 18.25 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.4 | $3.8M | 500k | 7.52 | |
Quanterix Ord (QTRX) | 0.3 | $3.3M | 202k | 16.19 | |
Galapagos Nv Spon Adr (GLPG) | 0.3 | $3.1M | 55k | 55.81 | |
Merus N V (MRUS) | 0.3 | $2.7M | 119k | 22.64 | |
BioCryst Pharmaceuticals (BCRX) | 0.3 | $2.5M | 240k | 10.58 | |
Align Technology Call Option (ALGN) | 0.2 | $2.4M | 10k | 236.70 | |
ImmunoGen | 0.2 | $2.3M | 500k | 4.50 | |
Insulet Corporation (PODD) | 0.2 | $1.6M | 7.2k | 217.90 | |
Geron Corporation (GERN) | 0.2 | $1.6M | 1.0M | 1.55 | |
Intra Cellular Therapies (ITCI) | 0.2 | $1.5M | 27k | 57.07 | |
Leap Therapeutics | 0.1 | $1.2M | 1.1M | 1.15 | |
Ikena Oncology (IKNA) | 0.1 | $975k | 220k | 4.43 | |
Eqrx *w Exp 12/17/202 | 0.0 | $81k | 100k | 0.81 | |
Longview Acquisition Corp Ii *w Exp 99/99/999 | 0.0 | $56k | 427k | 0.13 | |
Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $15k | 83k | 0.18 | |
Orion Acquisition Corp *w Exp 02/19/202 | 0.0 | $12k | 137k | 0.09 | |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $2.0k | 78k | 0.03 |